A federal judge in Baltimore issued a 10-day restraining order, blocking the shipment and sales of Fluticasone Propionate Nasal Spray (from Roxane Laboratories Inc.'s , FDA-approved last week)...
Read the full post.
Laboratory Corporation of America Holdings (LabCorp) acquired the rights to commercialize a diagnostic blood test for epithelial ovarian cancer (EOC) developed at Yale University. "Ovarian...
Read the full post.
In a revised, expanded agreement, Amgen receives exclusive worldwide rights to develop and commercialize Biovitrum's drug candidate for Type 2 diabetes and related metabolic Diseases. Previously,...
Read the full post.
What: 2006 Florida Tech Transfer Conference When: May 22-23, 2006 Where: Ritz-Carlton Sarasota This year's conference will exhibit Florida's top research university technologies available for...
Read the full post.
The chemical company Bayer AG said Wednesday it has acquired Icon genetics AG, a biotech company working on methods for the development and use of engineered plants for producing pharmaceuticals and...
Read the full post.
It's the start of the new year and naturally, everyone wants to know: How do the prospects for biotechnology look like for the year 2006? According to CNN Money, biotech will remain to be good...
Read the full post.
Avian flu has now reportedy reached as far as UK. With the threat of a global pandemic becoming more and more real, generic drug manufacturers are getting more and more eager to secure permission from...
Read the full post.
In a world first, a patent which encompasses 'vector expressed' siRNAs targeting a disease gene has been issued by the Australian Patent Office. The patent, which broadly covers all vector...
Read the full post.
Don't you wish there were more banks and institutes like the Austria Wirtschaftsservice Gesellschaft m.b.H. (aws) who facilitate the marketing of promising innovations and technologies? In this...
Read the full post.
GlaxoSmithKline's (GSK) patent for AZT (Retrovir� or zidovudine), the very first AIDS drug, ends today, seventeen years after it was first patented for use against HIV/AIDS. The AIDS Healthcare...
Read the full post.
Novartis AG gets exclusive worldwide rights to NexMed's proprietary NM100060 nail lacquer treatment for onychomycosis, commonly known as nail fungus. NM100060 is currently in Phase 1 development...
Read the full post.
Fortune75 runs a lengthy article on the Bayh-Dole Act or Patent and Trademark Ammendments Act, which promoted the participation of universities and federally funded institution in the...
Read the full post.
Current methods od biometric identification-- fingerprints, iris patterns, hand geometry, and alike-- have already been fodder for fiction novels and sci-fi movies. And while they have already been...
Read the full post.
This press release states that InterImmune, Inc has been issued two composition of matter patents that together cover the manufacture, use and sale of Actimmune in the United States. These patents...
Read the full post.
According to a lawsuit filed by Danish biotech firm Bavarian Nordic, UK-based Acambis met with the firm previously to discuss licensing agreements, but when a $1.9B contract to supply the US...
Read the full post.
The ethical issues surrounding the use of embryonic stem cells could be circumvented, afterall. bone marrow cells have been shown to have the potential to develop into muscle cells, albeit with...
Read the full post.
Not all discoveries from basic research can be used to fuel a start-up biotech venture. Often, it makes better (financial) sense to simply license the intellectual property. Last week, for example,...
Read the full post.
